Funda, D. P., Palová-Jelínková, L., Goliáš, J., Kroulíková, Z., Fajstová, A., Hudcovic, T., & Špíšek, R. (2019). Optimal Tolerogenic Dendritic Cells in Type 1 Diabetes (T1D) Therapy: What Can We Learn From Non-obese Diabetic (NOD) Mouse Models? Front Immunol.
Citación estilo ChicagoFunda, David P., Lenka Palová-Jelínková, Jaroslav Goliáš, Zuzana Kroulíková, Alena Fajstová, Tomáš Hudcovic, and Radek Špíšek. "Optimal Tolerogenic Dendritic Cells in Type 1 Diabetes (T1D) Therapy: What Can We Learn From Non-obese Diabetic (NOD) Mouse Models?" Front Immunol 2019.
Cita MLAFunda, David P., et al. "Optimal Tolerogenic Dendritic Cells in Type 1 Diabetes (T1D) Therapy: What Can We Learn From Non-obese Diabetic (NOD) Mouse Models?" Front Immunol 2019.